Christopher Paul Simms, Officer of 4D Molecular Therapeutics FDMT, has filed 0 purchases and 1 sale on the open market. The latest trade was on 03/25.

Christopher Paul Simms

SEE REMARKS

Company: 4D Molecular Therapeutics FDMT
First filing: 23/01/04

Trades: 11 trades
Buys / sales: 0 / 1
12-month net buying: No record
Last trade: 03/25

Trading activity

Transactions

	Trade type
Iveric bio	Open-market sale	23/01/03	23/01/04	2,368 sh	$20.06	$47,502.08	−6.8%